Ann: International Value Investor Takes Strategic Stake in Uscom, page-9

I think it's too early to speculate on takeovers etc. These guys have their ducks lined up now and a serious vested personal interest from a real player in the china medical space.

I imagine they'll ramp up the Uscom 1A sales into Mr Mengs distribution channels (3000 distribution channels into 10,000+ Hospitals) and when BP+ and Spiro are CFDA approved it'll be an easy sell into these contacts.

This is just China remember. Us, Europe and Australia will be next. I said it earlier, Meng is a game changer and I'm going Long at these levels. 20m MC with the pipeline Meng has into China is simply too cheap.

Good luck guys